Skip to content

Smart Soft Contact Lenses for Monitoring Glaucoma

Smart Soft Contact Lenses for Continuous 24-hour Monitoring of Intraocular Pressure in Glaucoma Care

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07224542
Enrollment
120
Registered
2025-11-04
Start date
2025-10-19
Completion date
2028-09-30
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

glaucoma, contact lens, sensor, eye pressure, IOP, optometry, ophthalmology

Brief summary

This study is exploring the effectiveness and safety of soft contact lenses with embedded sensors, called smart contact lenses. Smart contact lenses are used to measure the pressure inside the eye.

Detailed description

Subjects first present for a single qualification visit (phase 1), then present for up to 3 short-term (\ 1 hour) in-clinic visits (phase 2), and finally have visits prior to and following a full day (phase 3). Efficacy outcomes of the smart contact lens are compared to standard clinical measures of eye pressure. Safety outcomes of the smart contact lens are compared to those of traditional soft contact lenses.

Interventions

DEVICEBare Contact Lens

Commercially available contact lens without a sensor

DEVICEExperimental Smart Contact Lens

Sensor contact lens being studied

DEVICECommercially available smart contact lens

The Triggerfish ocular monitoring system includes a disposable silicone soft contact lens with an embedded sensor, a wireless antenna, and a portable recorder.

Sponsors

Indiana University
Lead SponsorOTHER
National Eye Institute (NEI)
CollaboratorNIH
Purdue University
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Glaucomatous Arm Inclusion Criteria * 22+ years of age * Able to wear soft contact lenses * Previously diagnosed, currently pharmaceutically treated Primary Open Angle Glaucoma (POAG) Non-Glaucomatous (Healthy Older Adults) Arm Inclusion Criteria * 22+ years of age * Able to wear soft contact lenses * Without glaucomatous disease

Exclusion criteria

for all arms: * Unable to complete the study procedures * Ocular disease other than glaucoma (if applicable) * Significant acute or chronic medical, neurologic, or other illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study and/or is contradicted for soft contact lens or sensor lens use

Design outcomes

Primary

MeasureTime frameDescription
Goldmann Applanation Intraocular PressurePhase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 daysThe IOP of participants will be measured with the Goldmann applanation tonometry (GAT) prior to and following device use, and in the contralateral eye during device use. A \>2 mmHg difference in is considered clinically significantly different.
I-Care Tonometry Intraocular PressurePhase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 daysThe I-Care (I-Care, Inc.) tonometry will also be evaluated during contralateral eye device use. A \>2 mmHg difference in is considered clinically significantly different.
Lens comfortPhase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 daysParticipant-reported comfort will be assessed using a simple 100-point numeric scale where a rating of '100' represents extremely uncomfortable/intolerable and a rating of '1' perfectly comfortable/not noticeable at all. Comfort assessments will occur prior to, during, and following all device use to allow comparisons to typical or comparator devices. A 7-point difference in ratings is considered clinically significantly different.
Lens FitPhase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 daysLens fit will be measured with slit lamp during lens wear and graded using the Cornea and Contact Lens Research Unit (CCLRU) grading scale, which ranges from 0 to 4 with a rating of 0 representing an optimal outcome. A difference of 1.0 grading unit will be considered clinically significant.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPete S Kollbaum

Indiana University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026